Analgesic Agents
Analgesic Agents - Related Videos
11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 5 •
2016
This protocol describes the preparation and characterization of a dendrimeric magnetic resonance imaging (MRI) contrast agent that carries cyclen-based macrocyclic chelates coordinating paramagnetic gadolinium ions. In a series of MRI experiments in vitro, this agent produced an amplified MRI signal when compared to the commercially available monomeric analogue.
02:25
Synergistic Effect of Intracranial and Intraperitoneal Delivery of Analgesic Drugs on Thermal Pain Response in a Rat
0 Views •
2025
Source: Martinez, E., et al. Intracranial Pharmacotherapy and Pain Assays in Rodents. J. Vis. Exp. (2019).This video demonstrates the intracranial administration of an analgesic drug in an anesthetized rat with a pre-implanted guide cannula in the prefrontal cortex. An additional analgesic drug is co-administered intraperitoneally. Following recovery, the rat’s thermal pain response is assessed using Hargreave’s apparatus, where paw withdrawal latency is measured to evaluate the analgesic...
10:19
Reducing Agents
0 Views •
2023
Source: Vy M. Dong and Daniel Kim, Department of Chemistry, University of California, Irvine, CA Controlling the reactivity and selectivity during the synthesis of a molecule is very important criteria for chemists. This has led to the development of many reagents that allow chemists to pick and choose reagents suitable for a given task. Quite often, a balance between reactivity and selectivity needs to be achieved. This experiment will use IR spectroscopy to monitor the reaction and to...
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
0 Views •
Cited by 41 •
2014
We describe a protocol to examine the development of opioid-induced hyperalgesia and tolerance in mice. Based on the measurement of thermal and mechanical nociceptive responses of naïve and morphine-treated animals, it allows to quantify the increase in pain sensitivity (hyperalgesia) and decrease in analgesia (tolerance) associated with chronic opiate administration.
01:15
Opioid Analgesics: Synthetic and Semisynthetic Opioids
0 Views •
2024
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
FAQs
Cyclooxygenase inhibitors act by reducing cyclooxygenase enzyme activity, which lowers prostaglandin production. Because prostaglandins participate in biological signaling associated with pain, changing their production provides a mechanism distinct from directly altering central nervous system receptor activity. This pathway helps explain why nonsteroidal anti-inflammatory drugs are studied separately from opioid and nerve-modifying agents.
Some analgesic agents activate opioid receptors, producing changes in pain signaling within the central nervous system. This mechanism differs from reducing prostaglandin production or modifying activity in peripheral nerves. Comparing these pathways helps biologists connect receptor activity with altered nociception, the biological process through which potentially harmful stimuli are detected and processed.
Local anesthetics are distinguished by their effects on peripheral nerve activity, whereas opioid agents alter pain signaling through receptors in the central nervous system. This difference is important because the site of action helps organize analgesic agents into mechanistic categories. It also provides a biological framework for comparing how pain signals are modified before or within the nervous system.
Analgesic agents are studied as distinct groups because they do not all act through the same biological pathway. Nonsteroidal anti-inflammatory drugs affect cyclooxygenase and prostaglandin production, opioids act at opioid receptors, and local anesthetics modify peripheral nerve activity. Recognizing these differences supports clearer comparisons of mechanisms, effects, benefits, and risks across agents.
In pain research, analgesic agents help investigators examine nociception and evaluate changes in pain responses. Applying agents with different mechanisms can connect an observed response with cyclooxygenase activity, opioid receptor signaling, or peripheral nerve modulation. This makes analgesic studies useful for investigating biological pain pathways and for comparing potential treatment effects.
Comparative studies can reveal how distinct biological targets influence pain responses and can help separate central nervous system effects from peripheral or prostaglandin-related mechanisms. Researchers also use these comparisons to assess benefits and risks among nonsteroidal anti-inflammatory drugs, acetaminophen, opioids, and local anesthetics. Such evidence contributes to the development of safer approaches to pain treatment.